Clinical Trial

A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

Name: A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal — clinical trial record (NCT07333742)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

Bioequivalence study for the fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg under fed conditions in healthy volunteers

Trial Details

NCT Number	NCT07333742
Lead Sponsor	LG Chem
Conditions	Fed Conditions, Healthy Volunteer
Enrollment	50 participants
Start Date	2025-09-29
Primary Completion	2025-11-27 (estimated)
Study Completion	2025-11-27 (estimated)
Updated on ClinicalTrials.gov	2026-01-12